mTOR Inhibitors in the complex treatment of high-risk vascular malformations in children
Recent experimental and clinical studies demonstrated that mTOR receptor inhibitors can stop the progression of vascular malformations and significantly improve patients’ quality of life. This is possible due to the interruption of the chain of phosphatidylinositol-3-kinase (PI3K) / AKT / mTOR react...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Group of Companies Med Expert, LLC, Kyev, Ukraine
2020-06-01
|
| Series: | Хірургія дитячого віку |
| Subjects: | |
| Online Access: | http://psu.med-expert.com.ua/article/view/PS.2020.67.6 |